Research indicates that demand for minimally invasive prostatectomy is growing, from 12 percent to more than 30 percent of our candidate patients over a recent two-year span. But research also tells us that there are still drawbacks to a laparoscopic approach to prostate cancer. What are the immediate and enduring pitfalls to laparoscopy, and are these concerns outweighed by the perceived benefits? Dr. Jim Hu, assistant professor of surgery at Harvard Medical School, and director of minimally invasive urologic oncology at Brigham and Women's Hospital and the Dana Farber Cancer Institute in Boston, explains why some surgeons may stick with the open procedure, even as others move ahead with the laparoscopic approach. Dr. Mark Nolan Hill hosts.
Prostate Cancer: Laparoscopic v. Open Procedures
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Research indicates that demand for minimally invasive prostatectomy is growing, from 12 percent to more than 30 percent of our candidate patients over a recent two-year span. But research also tells us that there are still drawbacks to a laparoscopic approach to prostate cancer. What are the immediate and enduring pitfalls to laparoscopy, and are these concerns outweighed by the perceived benefits? Dr. Jim Hu, assistant professor of surgery at Harvard Medical School, and director of minimally invasive urologic oncology at Brigham and Women's Hospital and the Dana Farber Cancer Institute in Boston, explains why some surgeons may stick with the open procedure, even as others move ahead with the laparoscopic approach. Dr. Mark Nolan Hill hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
Updates From the 7th World Symposium Task Force
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
HF Management for Patients with Comorbid Conditions
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
mIDH Gliomas Explained: Characteristics and Management Strategies
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?